Emcure Pharmaceuticals IPO Subscription Status
Emcure Pharmaceuticals IPO was subscribed 68.41 times when bidding closed on 5 Jul 2024: QIB 191.24x, NII 49.32x, Retail 7.36x.
The Emcure Pharmaceuticals IPO has been subscribed 68.41x times overall. Retail investors have shown interest with bids for 7.36x the shares available. The Non-Institutional Investor (NII) category has been subscribed 49.32x. Within NII, Big HNI (B-HNI) subscribed 54.9x and Small HNI (S-HNI) subscribed 38.16x. Qualified Institutional Buyers (QIBs) have subscribed 191.24x. Data last updated on 10 Nov, 06:45 PM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 03 Jul, 2024 and closes on 05 Jul, 2024. The shares are expected to list on stock exchanges on 10 Jul, 2024.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | - of - - | 191.24x |
| NII | - of - - | 49.32x |
bHNI — bid amount above ₹10 Lakh |
- - | 54.9 |
sHNI — bid amount ₹2–10 Lakh |
- - | 38.16 |
| Retail | - of - - | 7.36x |
| Employee | - of - - | 8.81x |
| TOTAL | - - | 68.41x |
Emcure Pharmaceuticals IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 13.6% for a single lot.
Institutional Backing
Massive institutional interest with QIBs subscribing 191.24x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
05 Jul 2024
Day 3 |
68.41x | ▼ | |
|
QIB191.24x
BHNI54.9x
SHNI38.16x
Retail7.36x
Employee8.81x
|
|||
|
04 Jul 2024
Day 2 |
4.98x | ▼ | |
|
QIB1x
BHNI14.15x
SHNI12.7x
Retail3.43x
|
|||
|
03 Jul 2024
Day 1 |
1.32x | ▼ | |
|
QIB0.07x
BHNI2.54x
SHNI3.04x
Retail1.39x
|
|||
Emcure Pharmaceuticals IPO dates
From the bidding window to listing. Today is 11 November.
- Open 03 Jul 2024
- Close 05 Jul 2024
- Allotment 08 Jul 2024
- Refund/credit 09 Jul 2024
- Listing 10 Jul 2024
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Emcure Pharmaceuticals IPO?
As of IPO close date (05 Jul, 2024), the Emcure Pharmaceuticals IPO is subscribed 68.41x times. Retail category is 7.36x, and NII is 49.32x subscribed.
When is the allotment date for Emcure Pharmaceuticals IPO?
The allotment for Emcure Pharmaceuticals IPO is expected to be finalized on 08 July, 2024.
What is the GMP of Emcure Pharmaceuticals?
The Grey Market Premium (GMP) for Emcure Pharmaceuticals is currently ₹360, indicating a potential listing gain of 36%.
When will Emcure Pharmaceuticals IPO list on the stock market?
Emcure Pharmaceuticals is scheduled to list on BSE and NSE on 10 July, 2024.
What are the chances of getting allotment in Emcure Pharmaceuticals IPO?
The retail category is oversubscribed at 7.36x, meaning allotment is by lottery. Statistically, approximately 1 in 8 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 191.24x mean for Emcure Pharmaceuticals IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 191.24x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Emcure Pharmaceuticals IPO allotment status?
After the allotment date (08 Jul, 2024), you can check your Emcure Pharmaceuticals IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Emcure Pharmaceuticals IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.
